Skip to main content
OpenTrials
Completed

NCT Number: NCT07235553

Non-inferiority Investigation to Evaluate the Efficacy and Safety of the Ultrasonic Surgical System

The objective of this clinical investigation is to evaluate the efficacy and safety of the Ultrasonic Surgical System in the clinical application produced by Ezisurg Medical Co., Ltd.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Beijing Hospital

Beijing, Beijing Municipality, 100730, China

About this study

This clinical investigation is designed as a prospective, multi-center, randomized, parallel-controlled non-inferiority investigation, and the HARMONIC System produced by Ethicon Endo-Surgery, LLC is used as the control product.

Study objective:To evaluate the efficacy and safety of the Ultrasonic Surgical System in the clinical application produced by Ezisurg Medical Co., Ltd.

Target population:Patients who require open or endoscopic surgery using the Ultrasonic Surgical Instruments.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects who voluntarily participate in the investigation and sign the Informed Consent Form;
  • Male or female subjects aged 18~75;
  • Patients who require open or endoscopic surgery using the Ultrasonic Surgical System;
  • Those who can communicate well with investigators and comply with investigational requirements.

Exclusion criteria

  • Patients with severe heart, liver, lung, kidney, brain, blood system diseases, severe metabolic diseases or unable to withstand surgery after systemic assessment;
  • Those who with obvious severe local or systemic infection;
  • Those who need to undergo the resection of bone tissue and central nervous tissue of the brain and the spinal cord;
  • Those who need to undergo contraceptive tubal ligation;
  • Those who have a history of alcohol or drug abuse within 6 months before the investigation;
  • Women who are pregnant or lactating, or women who plan to become pregnant within 6 months;
  • Those who with mental illness;
  • Those who have a history of allergies to multiple types of drugs or recent allergic diseases;
  • Those who have participated in other clinical investigations in the past 3 months;
  • Those who are inappropriate to participate in this clinical investigation for other reasons in the opinion of the investigators.

Treatment and study plan

Ultrasonic Surgical System

Device

Generator: ES01; single use shear: SHC23A, SHC36A; handpiece: eHP01

HARMONIC System

Device

Generator: GEN04; single use shear: ACE23E, ACE36E; handpiece: HP054

Primary outcomes

  1. The overall excellent performance rate

    Time frame: during the surgery

    The overall excellent performance rate will be taken as the primary evaluation indicator. The clinical effect of the investigational product is mainly embodied by its cutting and coagulation functions, and the surgical operators will evaluate the cutting and coagulation functions of the product according to the following criteria.

Sponsors and collaborators

Lead sponsor

Ezisurg Medical Co. Ltd.

Other

Collaborators

  • Beijing Hospital
  • China-Japan Union Hospital, Jilin University
  • Peking University Third Hospital

Registry information

Official study title

A Prospective, Multi-center, Randomized, Open-label, Parallel-controlled Non-inferiority Investigation to Evaluate the Efficacy and Safety of the Ultrasonic Surgical System in Clinical Applications

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Nov 19, 2025
Registry last updated
Nov 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.